Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra ‐central non‐small cell lung cancer

ConclusionSBRT with a moderate dose in 4 –6 fractions is effective and tolerable for patients with advanced stage UC‐NSCLC. However, caution should be taken considering possible treatment‐related death. Further studies are warranted.

Source: Thoracic Cancer - June 10, 2019 Category: Cancer & Oncology Authors: Yang Cong, Bing Sun, Junliang Wang, Xiangying Meng, Liang Xuan, Junjian Zhang, Jiannan Liu, Ge Shen, Shikai Wu Tags: ORIGINAL ARTICLE Source Type: research